Bal Pharma Limited (BALPHARMA) — Corporate Action | 25 August 2026

25 August 2026 · NSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Clarified 18-month utilization timeline for preferential issue proceeds

💡 Investor Takeaway

Investors should note the proceeds have a strict 18-month deployment deadline, which may affect capital allocation timing.

Bal Pharma clarified that the net proceeds from its recent preferential issue of convertible warrants must be utilized within 18 months of allotment, subject to stock exchange approval, with no change to the issue's purpose or fund usage plan.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BALPHARMA ✨ Ask AI About This

About Bal Pharma Limited (BALPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹177.95 CrP/E: 24.6ROE: 8.8%ROCE: 10.0%Div Yield: 1.07%

View full BALPHARMA stock details →

📡 Get AI alerts when BALPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track BALPHARMA — Free

💡 Ask AI about this filing

"When were the convertible warrants allotted?""What specific uses are planned for the preferential issue proceeds?""Has the stock exchange approved the utilization timeline?"

Ask AI Free →

📊 More BALPHARMA filings

Announcement — 25 September 2026Bal Pharma Ltd announced the closure of its trading window effective October 1, 2026, until 48 hours...
🟡 Board Meeting — 25 September 2026Bal Pharma announced at its September 24, 2026 AGM the re-appointment of Ravindra Kumar Kothari as D...
🟡 Board Meeting — 24 September 2026Bal Pharma held its 39th AGM on September 24, 2026, approving a Rs. 1.20 per share dividend for FY20...
Announcement — 10 September 2026Bal Pharma clarified that recent price volatility in its shares is market-driven with no price-sensi...
🔴 Corporate Action — 7 September 2026Bal Pharma announced the allotment of 10 lakh convertible warrants to promoter Shailesh Siroya at ₹8...

See all BALPHARMA filings →

🔥 Also filed on 25 August 2026

EPLEPL LimitedAnnual Report AMANTAAmanta Healthcare LimitedAnnual Report ZEELZee Entertainment Enterprises LimitedAnnual Report FINKURVEFinkurve Financial Services LimitedCorporate Action EPLEPL LimitedAnnual Report ARVINDArvind LimitedAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BALPHARMA files new disclosures

Track BALPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.